Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
684 Assay development and quantitative detection of ADI-001, a CD20-targeted γδ1 CAR T therapy, using AlloCell, a universal assay for monitoring of off-the-shelf allogeneic cell therapies
Compose a Response to This Article
Other responses
No responses have been published for this article.
